research
Families Named the Friction Around Pediatric Cancer Trials
Interviews with Black and Hispanic parents and clinicians identified trust, material hardship and consent design as enrollment factors.
Summary
Interviews with Black and Hispanic parents and clinicians identified trust, material hardship and consent design as enrollment factors.
UT Southwestern researchers interviewed 60 Black or Hispanic parents of children with cancer and 15 Dana-Farber clinicians about clinical-trial participation. Seventy-three percent of families reported material hardship; participants also described trust, altruism, consent readability and clinician gatekeeping as factors. The single-center qualitative study surfaces actionable barriers but does not measure whether a specific intervention raises enrollment.
Why it matters
Interviews with Black and Hispanic parents and clinicians identified trust, material hardship and consent design as enrollment factors.
Limits and context
- The single-center qualitative study surfaces actionable barriers but does not measure whether a specific intervention raises enrollment.
Key claims
Interviews with Black and Hispanic parents and clinicians identified trust, material hardship and consent design as enrollment factors.
Qualification: The single-center qualitative study surfaces actionable barriers but does not measure whether a specific intervention raises enrollment.
Evidence: source-2026-08-01-012
Sources
- UT Southwestern via Newswise: Pediatric oncology trial enrollmentUT Southwestern Medical Center via Newswise · secondary reporting
Corrections
No corrections have been recorded for this story.